Cover Image
Market Research Report

Generics BRIC (Brazil, Russia, India, China) Industry Guide 2017-2021

Published by MarketLine Product code 483010
Published Content info 110 Pages
Delivery time: 1-2 business days
Back to Top
Generics BRIC (Brazil, Russia, India, China) Industry Guide 2017-2021
Published: February 28, 2018 Content info: 110 Pages


The BRIC Generics industry profile provides top-line qualitative and quantitative summary information including: market size (value and volume 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.


Essential resource for top-line data and analysis covering the BRIC generics market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

Brazil, Russian Federation, India and China (BRIC) are the emerging and fast growing countries within the generics industry and had a total market value of $81,615.2 million in 2016. Russia was the fastest growing country with a CAGR of 15.1% over the 2012-16 period.

Within the generics industry, China is the leading country among the BRIC nations with market revenues of $57,010.8 million in 2016. This was followed by India, Russia and Brazil with a value of $12,654.0, $6,617.8, and $5,332.6 million, respectively.

China is expected to lead the generics industry in the BRIC nations with a value of $87,161.6 million in 2021, followed by India, Russia, Brazil with expected values of $18,196.7, $12,616.9 and $10,359.5 million, respectively.


  • Save time carrying out entry-level research by identifying the size, growth, and leading players in the BRIC generics market
  • Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the BRIC generics market
  • Leading company profiles reveal details of key generics market players' BRIC operations and financial performance
  • Add weight to presentations and pitches by understanding the future growth prospects of the BRIC generics market with five year forecasts by both value and volume
  • Compares data from Brazil, Russia, India, and China, alongside individual chapters on each country
  • Reasons to buy
  • What was the size of the BRIC generics market by value in 2016?
  • What will be the size of the BRIC generics market in 2021?
  • What factors are affecting the strength of competition in the BRIC generics market?
  • How has the market performed over the last five years?
  • How large is the BRIC generics market in relation to its regional counterparts?
Table of Contents
Product Code: MLIG1744-04

Table of Contents

Introduction 11

What is this report about? 11

Who is the target reader? 11

How to use this report 11

Definitions 11

BRIC Generics 12

Industry Outlook 12

Generics in Brazil 15

Market Overview 15

Market Data 16

Market Segmentation 18

Market outlook 19

Five forces analysis 21

Macroeconomic indicators 27

Generics in China 29

Market Overview 29

Market Data 30

Market Segmentation 32

Market outlook 33

Five forces analysis 35

Macroeconomic indicators 41

Generics in India 43

Market Overview 43

Market Data 44

Market Segmentation 46

Market outlook 47

Five forces analysis 49

Macroeconomic indicators 55

Generics in Russia 57

Market Overview 57

Market Data 58

Market Segmentation 60

Market outlook 61

Five forces analysis 63

Macroeconomic indicators 69

Company Profiles 71

Leading Companies 71

Appendix 108

Methodology 108

About MarketLine 109

Back to Top